Coronavirus (COVID-19)—CMA announces successful engagement with PCR test provider

07 Dec 2021 | 1 min read

LNB News 03/12/2021 84

The Competition and Markets Authority (CMA) has announced that, following discussions, it has succeeded in securing changes from a major coronavirus (COVID-19) testing provider in the UK, Randox. The CMA raised concerns with Randox about its terms and conditions on cancellations, refunds and liability, which have now been revised by the PCR test provider.

The CMA’s engagement with Randox follows its open letter to PCR test providers which was issued on 25 August 2021.

This engagement led to the following changes in Randox’s terms and conditions:

• clearer information to be given to customers on details such as when it will provide PCR tests and results

• improving notification of customers’ legal rights on cancellations and refunds, for instance, making it clear to the customer if they have a right to a ‘cooling off’ period

• removing terms that could suggest to customers that they are not entitled to compensation if things go wrong

In addition, the CMA has sent letters to 25 other PCR providers warning them to review their terms and conditions, and other practices, or risk facing enforcement action.

For more information on the open letter see: LNB News 25/08/2021 21.

Source: CMA secures changes from major PCR testing provider

Try LexisNexis for free for 7 days

* denotes a required field

I confirm I am a lawyer or work in a legal capacity, intend to use LexisNexis products for business purposes and agree with the terms and conditions.^**

^**Free trials are only available to individuals based in the UK, Ireland and selected UK overseas territories and Caribbean countries. We may terminate this trial at any time or decide not to give a trial, for any reason.